Monoclonal antibody (MAb) 3B5 generated against canine mesothelioma cells was applied to canine tumors and normal tissues via immunohistochemical and immunoblotting techniques to evaluate antigen binding. By use of an avidin-biotin immunoperoxidase complex (ABC) method, immunoreactivity was noted in reactive mesothelial cells and in normal tissues was observed primarily in mesothelial cell linings, endothelial cells, and smooth muscle of blood vessels and soft tissues; the reactivity was nearly equivalent in frozen or formalin-fixed, paraffin-embedded tissue sections. Use of the ABC method on formalin-fixed, paraffin-embedded tumors yielded moderate to strong cytoplasmic immunostaining of neoplastic cells in 10/11 (91%) mesotheliomas, 18/23 (78%) hemangiosarcomas, 4/10 (40%) intestinal and lung carcinomas, and ≤20% of hemangiomas, leiomyosarcomas, leiomyomas, mammary carcinomas, and squamous cell carcinomas. No immunostaining of tumor cells was observed in fibrosarcomas, hemangiopericytomas, perianal gland carcinomas, and melanomas. Immunoblotting was performed on samples that demonstrated strong immunoreactivity with MAb 3B5 by the ABC method: mesothelioma, hemangiosarcoma, urinary bladder (smooth muscle), and lung (alveolar capillaries). These analyses showed that MAb 3B5 bound a major antigen of 78 kilodaltons (kd) and minor antigens at 56 and 54 kd in normal and neoplastic tissues. The preliminary immunohistochemical results suggest that MAb 3B5 may possess utility in diagnosis of mesotheliomas and hemangiosarcomas, discrimination of cell types in proliferative serosal lesions, and demonstration of vascularity or angiogenesis in neoplastic and inflammatory lesions.
AidaYOkadaKAmanumaH:
Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma.
Cancer Res53:
429–437,
1993.
2.
Al-NafussiACarderPJ:
Monoclonal antibodies in the cytodiagnosis of serous effusions.
Cytopathology1:
119–128,
1990.
3.
AndreasenCBMahaffeyEADuncanJR:
Intermediate filament staining in the cytologic and histologic diagnosis of canine skin and soft tissue tumors.
Vet Pathol25:
343–349,
1988.
4.
BaakJPAChinDVan DiestPJOrtizRMatze-CokPBacusSS:
Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Lab Invest64:
215–223,
1991.
5.
BenchimolSFuksAJothySBeaucheminNShirotaKStannersCP:
Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule.
Cell57:
327–334,
1989.
6.
BenzEW:
Intermediate filament proteins: a molecular basis for tumor diagnostics.
BioTechniques3:
412–420,
1985.
7.
BlobelGAMollRFrankeWWKayserKWGouldVE:
The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
Am J Pathol121:
235–247,
1985.
8.
BrownPJ:
Immunohistochemical localization of myoglobin in connective tissue tumors in dogs.
Vet Pathol24:
573–574,
1987.
9.
ClemoFASDeNicolaDBDelaneyLJ:
Immunohistochemical evaluation of canine carcinomas with monoclonal antibody B72.3.
Vet Pathol30:
140–145,
1993.
10.
CollinsCLOrdonezNGSchaeferRCookCDXieSSGrangerJHsuPLFinkLHsuSM:
Thrombomodulin expression in malignant pleural mesothetioma and pulmonary adenocarcinoma.
Am J Pathol141:
827–833,
1992.
11.
DasteGSerreGMauduytMAVincentCCaverivierePSoleihavoupJ:
Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Cytopathology2:
19–28,
1991.
12.
DempseyPJFeleppaFPBrownRWde KretserTAWhiteheadRHJoseDG:
Development of monoclonal antibodies to human breast carcinoma cell line PMC 42.
J Natl Cancer Inst77:
1–9,
1986.
13.
DestexheELespagnardLDegeyterMHeymannRCoignoulF:
Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors.
Vet Pathol30:
146–154,
1993.
14.
EstebanJMBattiforaH:
Tumor immunophenotype: comparison between primary neoplasm and its metastases.
Mod Pathol2:
192–197,
1990.
15.
FidlerIJ:
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Cancer Res38:
2651–2660,
1978.
16.
GangopadhyayAWolfeLG:
Conserved antigen expression in epithelial tumors recognized by monoclonal antibody 4A9 generated against canine mammary carcinoma cells.
Hybridoma8:
175–186,
1989.
17.
GreinerJWHoran HandPColcherDWeeksMThorANoguchiPPestkaSSchlomJ:
Modulation of human tumor antigen expression.
J Lab Clin Med109:
244–261,
1987.
18.
GriffeySMMadewellBRDairkeeSHHuntJENaydanDKHigginsRJ:
Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
Vet Pathol30:
155–161,
1993.
19.
HainesDMMatteGWilkinsonAANoujaimAATurnerCLongeneckerBM:
Immunohistochemical staining and radionuclide imaging of canine tumors, using a monoclonal antibody recognizing a synthetic carbohydrate antigen.
Am J Vet Res50:
875–881,
1989.
20.
HellmenELindgrenA:
The expression of intermediate filaments in canine mammary glands and their tumors.
Vet Pathol26:
420–428,
1989.
21.
HendrixMJCSeftorEAChuYWSeftorREBNagleRBMcDanielKMLeongSPLYohemKHLeibovitzAMMeyskensFLConawayDHWelchDRLiottaLAStetler-StevensonW:
Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential.
J Natl Cancer Inst84:
165–174,
1992.
22.
Horan HandPNutiMColcherDSchlomJ:
Definition of antigenic heterogeneity and modulation among human mammary adenocarcinoma cell populations using monoclonal antibodies to tumor associated antigens.
Cancer Res43:
728–735,
1983.
23.
HsuSMHsuPLZhaoXChien SongKSJacquelineWP:
Establishment of human mesothelioma cell lines (MS-1, −2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential.
Cancer Res48:
5228–5236,
1988.
24.
HsuSMRaineLFangesH:
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
J Histochem Cytochem29:
577–580,
1981.
25.
KohlerGMilsteinC:
Continuous cultures of fused cells secreting antibody of predefined specificity.
Nature256:
495–497,
1975.
26.
KuhlmannLBerghauserKHSchafferR:
Distinction of mesothelioma from carcinoma in pleural effusions: an immunocytochemical study on routinely processed cytoblock preparations.
Pathol Res Pract187:
467–471,
1991.
27.
LaemmliUK:
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature227:
680–685,
1970.
28.
LindsayDSDubeyJPBlagburnBL:
Characterization of monoclonal antibodies generated against Toxoplasma gondii tachyzoites.
J Ala Acad Sci61:
144,
1990.
29.
LloydRVSissonJCShapiroBVerhofstadAAJ:
Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors.
Am J Pathol125:
45–54,
1986.
30.
LowsethLAGillettNAChangIYMuggenburgBABoeckerBB:
Detection of serum α-fetoprotein in dogs with hepatic tumors.
J Am Vet Med Assoc199:
735–741,
1991.
31.
MarkwellMAKHassSMBieberLLTolbertNE:
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.
Anal Biochem87:
206–210,
1978.
32.
McDonoughSPMacLachlanNJTobiasAH:
Canine pericardial mesothelioma.
Vet Pathol29:
256–260,
1992.
33.
McNuttMABolenJWGownAMHammarSPVogelAM:
Co-expression of intermediate filaments in human epithelial neoplasms.
Ultrastruct Pathol9:
31–44,
1985.
34.
MooreASMadewellBRLundJK:
Immunohistochemical evaluation of intermediate filament expression in canine and feline neoplasms.
Am J Vet Res50:
88–92,
1989.
35.
OliverJL IIIWolfeLG:
Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
Am J Vet Res53:
123–128,
1992.
36.
PageCRoseMYacoubMPigottR:
Antigenic heterogeneity of vascular endothelium.
Am J Pathol141:
673–683,
1992.
37.
PatnaikAKLiebermanPH:
Gross, histologic, cytochemical, and immunocytochemical study of medullary thyroid carcinoma in sixteen dogs.
Vet Pathol28:
223–233,
1991.
38.
PorterPLBiglerSAMcNuttMGownAM:
The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature.
Mod Pathol4:
46–52,
1991.
39.
PulleyLTSiannardAA:
Tumors of the skin and soft tissues.
In:
Tumors in Domestic Animals,
ed. MoultonJE,
3rd ed.,
pp. 23–87.
University of California Press,
Berkeley, CA,
1990.
40.
SanduskyGEWightmanKACarltonWW:
Immunocytochemical study of tissues from clinically normal dogs and of neoplasms, using keratin monoclonal antibodies.
Am J Vet Res52:
613–618,
1991.
41.
SchlomJ:
Antibodies in cancer therapy: basic principles of monoclonal antibodies.
In:
Biologic Therapy of Cancer,
ed. De VitaVTJrHellmanSRosenbergSA,
pp. 464–481.
J. B. Lippincott,
Philadelphia, PA,
1991.
42.
StahelRAO'HaraCJWaibelRMartinA:
Monoclonal antibodies against mesothelial membrane antigen discriminate between malignant mesothelioma and lung adenocarcinoma.
Int J Cancer41:
218–223,
1988.
43.
SteplewskiZJeglumKARosalesCWeintraubN:
Canine lymphoma-associated antigens defined by murine monoclonal antibodies.
Cancer Immunol Immunother24:
197–201,
1987.
44.
ThorAOhuchiNSzpakCAJohnstonWWSchlomJ:
Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B 72.3.
Cancer Res46:
3118–3124,
1986.
45.
TowbinHStaehelinTGordonJ:
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc Natl Acad Sci USA76:
4350–4354,
1979.
46.
TrigoFJMorrisonWBBreezeRG:
An ultrastructural study of canine mesothelioma.
J Comp Pathol91:
531–537,
1981.
47.
UrbanJLSchreiberH:
Tumor antigens.
Annu Rev Immunol10:
617–644,
1992.
48.
WuYJParkerLMBinderNEBeckettMASinardJHGriffithsCTRheinwaldJG:
The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia.
Cell31:
693–703,
1982.
49.
YokoyamaWM:
Production of antibodies.
In:
Current Protocols in Immunology,
ed. ColliganJEKruisbeekAMMarguliesDHShevachEMStroberW,
vol. 1,
pp. 2.
4.1–2.5.17.
Greene/Wiley-Interscience,
New York, NY,
1992.
50.
YonezawaSMaruramaISakaeKIgataAMajerusPWSatoE:
Thrombomodulin as a marker for vascular tumors: comparative study with factor VIII and Ulex europaeus I lectin.
Am J Clin Pathol88:
405–411,
1987.
51.
ZarboRJGownAMNagleRBVisscherDWCrissmanJD:
Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas.
Mod Pathol4:
494–501,
1990.
